Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 31;24(1):481.
doi: 10.1186/s12876-024-03570-8.

Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey

Affiliations

Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey

Ailsa Hart et al. BMC Gastroenterol. .

Abstract

Background and aims: The co-existence of fatigue, pain and faecal incontinence in people with Inflammatory Bowel Disease (IBD) is unknown. We aimed to determine the presence of and relationship between these symptoms and patients' desire for intervention.

Methods: Adults with IBD in the UK, recruited from clinics, the national IBD-BioResource, a patient charity and social media sources, completed PROMIS validated patient-reported questionnaires to identify fatigue, pain and faecal incontinence, in addition to symptom severity and impact, disease activity, anxiety and depression questionnaires and questions about their desire for help with these symptoms. Statistical analysis used descriptive statistics to report presence of symptoms and Pearson correlation coefficients were calculated.

Results: Of 8486 responses, 54% reported faecal incontinence, 24% reported fatigue, and 21% reported pain; 10% reported all three symptoms in the past 7 days. Only 29% reported none of these symptoms. Fatigue and pain were moderately correlated (Pearson correlation coefficient 0.57); both fatigue and pain had a lower correlation with faecal incontinence (0.43 and 0.46 respectively). On a 0-10 scale for severity, participants scored fatigue highest, followed by incontinence then pain. For impact, participants scored incontinence highest, followed by fatigue then pain. 56% reported depression (27% with clinically relevant levels) and 49% reported anxiety (20% with clinically relevant levels); 23% had previously medically diagnosed mental health disorders. 56% of respondents "definitely" wanted help for fatigue; 53% for incontinence; 42% for pain; 29% "definitely" wanted help with all three symptoms. Factors associated with all three symptoms were Crohn's disease (vs. ulcerative colitis), IBD activity, IBD Control score, anxiety, depression, and history of surgery (all p ≤ 0.0001).

Conclusions: Fatigue, pain and incontinence are common in IBD and patients desire help for these symptoms, currently a substantial unmet need. Anxiety and depression are common, are underdiagnosed, and are independently associated with these symptoms.

Keywords: Crohn’s disease; Faecal incontinence; Fatigue; Inflammatory bowel disease; Pain; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Ethics approval was received from North West - Greater Manchester West Research Ethics Committee (Reference no: 18/NW/0613) on 11th October 2018. Informed consent to participate was obtained from all participants either in writing (postal) or online before accessing the online version of the survey. The study conformed to the requirements of the Helsinki declaration and the principles of Good Clinical Practice (GCP). Consent for publication: Not applicable. Competing interests: Ailsa Hart: has served as consultant, advisory board member or speaker for AbbVie, Arena, Atlantic, Bristol-Myers Squibb, Celgene, Celltrion, Falk, Galapogos, Lilly, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the Global Steering Committee for Genentech.Laura Miller: NoneFionn Cléirigh Büttner: None.Thomas Hamborg: NoneSonia Saxena: is an NIHR Senior investigator, funded by the National Institute for Health Research (NIHR) School for Public Health Research Grant Reference Number NIHR 204000 and NIHR Northwest London Applied Research CollaborationRichard Pollok: has served as consultant, advisory board member, speaker and/or received educational grants from Dr Falk, Pharmacosmos, Takeda, Janssen, Napp pharmaceuticals and Ferring pharmaceuticals.Imogen Stagg: NoneVari Wileman: NoneQasim Aziz: Funding as PI from Classado Biosciences Ltd; Takeda Pharmaceuticals and Dr Falk Pharma UK for commercial clinical trials. Wladyslawa Czuber-Dochan: Speaker fees from Dr Falk Pharma and research funding from Bristol Myers Squibb and Crohn’s and Colitis UKLesley Dibley: funding to support research from Takeda, Janssen; speaker fees from Abbvie, Janssen and WedMD. BRUK advisory board. Borislava Mihaylova: None Rona Moss-Morris: NoneChris Roukas: NoneChristine Norton: Speaker fees from: Janssen, WebMD, Medscape, Merck Pharmaceutical; Tillotts Pharma UK. Pfizer advisory board.

Figures

Fig. 1
Fig. 1
flow chart of responses to the survey
Fig. 2
Fig. 2
Co-occurrence of IBD-related symptoms among survey respondents. Frequencies reported within each symptom “circle” of the Venn diagram sum to the frequencies reported in Additional file 3, Table S7 for IBD-related (i) pain (n = 1,769), (ii) fatigue (n = 2,036), and (iii) incontinence (n = 4,562). The integer outside the Venn diagram (n = 3,111) represents participants (i) reporting no IBD-related symptoms (n = 2,462) OR (ii) with missing data for at least one IBD-related symptom AND reporting no for other IBD-related symptoms (n = 649)
Fig. 3
Fig. 3
People reporting wanting help for symptoms. Frequencies reported within each symptom “circle” of the Venn diagram sum to the frequencies reported in Additional file 3, Table S8 for IBD-related (i) pain (n = 3,470), (ii) fatigue (n = 4,622), and (iii) incontinence (n = 4,121). Percentages reported in the Venn diagram do not agree with percentages reported in Additional file 3, Table S8 because a different denominator value is used for each (combination of) IBD-related symptom(s) in Additional file 3, Table S8 whereas the same denominator (N = 8,486) is used for the Venn diagram. The integer outside the Venn diagram (n = 2,689) represents participants (i) not wanting help for IBD-related symptoms (n = 2,276) OR (ii) with missing data on wanting help for at least one IBD-related symptom reporting not wanting help for other IBD-related symptoms (n = 413)

Similar articles

Cited by

References

    1. Wilson BS, Lonnfors S, Vermeire S, Greco M, Hommes DW, Bell C et al. The true impact of IBD: a European Crohn’s and Ulcerative Colitis patient life impact survey 2010-11. 2012 2012.
    1. Proudfoot H, Norton C, Artom M, Didymus E, Kubasiewicz S, Khoshaba K. Systematic review: targets for health interventions for faecal incontinence in inflammatory bowel disease. Scand J Gastroenterol. 2018;53(12):1476–83. - PubMed
    1. Artom M, Czuber-Dochan W, Sturt J, Norton C. Targets for health interventions for inflammatory bowel disease-fatigue. J Crohn’s Colitis. 2016;10(7):860–9. - PubMed
    1. Sweeney L, Moss-Morris R, Czuber-Dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Aliment Pharmacol Ther. 2018;47:715–29. - PubMed
    1. Norton C, Dibley L. Help-seeking for fecal incontinence in people with inflammatory bowel disease. J Wound Ostomy Cont Nurs. 2013;40(6):631–8. - PubMed

MeSH terms

LinkOut - more resources